Johnson & Johnson (0R34)
LSE
Closed
Aug 21, 2026
Day's Range
270.3952 wk Range
174.82Overview - 0R34 - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
28.22B
P/E (Trailing)
‪24.37‬
PEG Ratio
‪-213.20‬
Price / Book
‪7.68‬
EV / EBITDA
‪0.80‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪67.87%‬
Operating Margin
‪35.62%‬
Return on Assets
‪13.45%‬
Return on Equity
‪32.87%‬
Ownership
Shares Outstanding
2.40B
Price stats
50-Day Avg
‪255.38‬
200-Day Avg
‪233.49‬
Dividends
Frequency
Quarterly
Peers - 0R34 - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0R34LSEJohnson & Johnson+34.95%52-week change24.37P/E (Trailing)‪67.87%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
- 0P6SLSEBayer AG+41.21%52-week change19.01P/E (Trailing)‪-6.17%‬Profit Margin
- OGNLSEOrigin Enterprises plc+99.03%52-week change11.95P/E (Trailing)‪1.77%‬Profit Margin
- 0A9WLSEOrganon & Co.+33.69%52-week change3.14P/E (Trailing)‪12.22%‬Profit Margin
- BAYLSEBay Capital Plc+99.66%52-week change-3043.48P/E (Trailing)‪0.00%‬Profit Margin
- 0R1BLSEBiogen Inc.+36.88%52-week change—P/E (Trailing)‪8.32%‬Profit Margin
Profile Summary - 0R34 - Johnson & Johnson
About
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, focusing on pharmaceuticals in oncology, immunology, neuroscience, and other therapeutic areas, and MedTech, encompassing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
